ATE516797T1 - Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroid - Google Patents
Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroidInfo
- Publication number
- ATE516797T1 ATE516797T1 AT08718736T AT08718736T ATE516797T1 AT E516797 T1 ATE516797 T1 AT E516797T1 AT 08718736 T AT08718736 T AT 08718736T AT 08718736 T AT08718736 T AT 08718736T AT E516797 T1 ATE516797 T1 AT E516797T1
- Authority
- AT
- Austria
- Prior art keywords
- polyaphrone
- corticosteroid
- topical
- vitamin
- composition
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07251094A EP1970049A1 (de) | 2007-03-15 | 2007-03-15 | Polyaphron topische Zusammensetzung mit Vitamin D und Kortikosteroid |
| US11/905,163 US20080227759A1 (en) | 2007-03-15 | 2007-09-27 | Topical composition |
| GB0723728A GB0723728D0 (en) | 2007-03-15 | 2007-12-04 | Topical composition |
| PCT/GB2008/000894 WO2008110815A1 (en) | 2007-03-15 | 2008-03-14 | Polyaphron topical composition with vitamin d and corticosteroid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516797T1 true ATE516797T1 (de) | 2011-08-15 |
Family
ID=38294208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08718736T ATE516797T1 (de) | 2007-03-15 | 2008-03-14 | Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroid |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080227759A1 (de) |
| EP (2) | EP1970049A1 (de) |
| JP (1) | JP5414542B2 (de) |
| CN (2) | CN104815329A (de) |
| AR (1) | AR065740A1 (de) |
| AT (1) | ATE516797T1 (de) |
| AU (1) | AU2008224704B2 (de) |
| CA (1) | CA2680405C (de) |
| DK (1) | DK2139452T3 (de) |
| ES (1) | ES2368535T3 (de) |
| RU (1) | RU2466716C2 (de) |
| TW (1) | TWI434705B (de) |
| WO (1) | WO2008110815A1 (de) |
| ZA (1) | ZA200906382B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| EP2008651A1 (de) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | Biologisch erodierbares Patch |
| US20120238535A1 (en) * | 2009-02-23 | 2012-09-20 | Smith Jan G | Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
| AU2009357263B2 (en) * | 2009-12-22 | 2015-04-09 | Leo Pharma A/S | Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture |
| US20120322776A1 (en) * | 2009-12-22 | 2012-12-20 | Leo Pharma A/S | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
| KR101619077B1 (ko) | 2010-06-11 | 2016-05-10 | 레오 파마 에이/에스 | 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
| KR101368587B1 (ko) | 2010-12-27 | 2014-03-05 | 주식회사 삼양바이오팜 | 오심 또는 구토 방지용 조성물 |
| BR112013023458B1 (pt) | 2011-03-14 | 2020-04-07 | Drug Delivery Solutions Ltd | composição oftálmica, e, método para fabricar a composição oftálmica |
| CN104138352B (zh) * | 2013-04-19 | 2018-02-27 | 江苏知原药业有限公司 | 卡泊三醇非水凝胶 |
| TWI756168B (zh) * | 2015-02-02 | 2022-03-01 | 日商參天製藥股份有限公司 | 多微泡及其眼瞼投予 |
| KR101641372B1 (ko) * | 2015-05-08 | 2016-07-20 | (주)동구바이오제약 | 안정성과 피부투과율이 향상된 약학 조성물 |
| WO2017037663A1 (en) | 2015-09-02 | 2017-03-09 | Cadila Healthcare Limited | Topical compositions comprising corticosteroids |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| CA3025696A1 (en) * | 2016-06-03 | 2017-12-07 | Avexxin As | Combination therapy comprising a polyunsaturated ketone and a secosteroid |
| KR20190015320A (ko) * | 2016-06-03 | 2019-02-13 | 아벡신 에이에스 | 다중불포화 케톤 및 코르티코스테로이드를 포함하는 조합 치료요법 |
| CN109789111B (zh) | 2016-09-21 | 2021-11-16 | 埃维克辛公司 | 药物组合物 |
| GB201701583D0 (en) * | 2017-01-31 | 2017-03-15 | Drug Delivery Solutions Ltd | Topical composition |
| BE1026073B1 (nl) * | 2018-03-05 | 2019-10-07 | Purna Pharmaceuticals Nv | Verbeterde werkwijze voor het maken van een farmaceutische emulsie |
| EP3542788A1 (de) * | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat |
| CN108653195A (zh) * | 2018-08-08 | 2018-10-16 | 江苏知原药业有限公司 | 透皮或透粘膜给药制剂 |
| CN114159567B (zh) * | 2020-09-10 | 2023-03-31 | 南京海融医药科技股份有限公司 | 一种治疗皮肤病的混悬凝胶剂 |
| CN113267390B (zh) * | 2021-05-11 | 2023-05-05 | 北京丹大生物技术有限公司 | 一种用于滤纸干血片的检测标志物洗脱液及其应用 |
| CN115569199B (zh) * | 2022-02-14 | 2024-08-20 | 海勃(上海)医药科技有限公司 | 一种药物组合物及其制备方法和应用 |
| CN114588102B (zh) * | 2022-03-18 | 2024-11-05 | 南京海融医药科技股份有限公司 | 一种治疗炎症性皮肤病的混悬凝胶剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3779907A (en) * | 1970-04-13 | 1973-12-18 | Exxon Research Engineering Co | Liquid membrane process for the separation of aqueous mixtures |
| GB1541463A (en) * | 1975-10-11 | 1979-02-28 | Lion Dentifrice Co Ltd | Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase |
| US4486333A (en) * | 1981-04-10 | 1984-12-04 | Felix Sebba | Preparation of biliquid foam compositions |
| CA1272953A (en) * | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
| US4999198A (en) * | 1989-03-23 | 1991-03-12 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Polyaphrons as a drug delivery system |
| ES2388425T5 (es) * | 1999-04-23 | 2020-02-12 | Leo Pharma As | Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente |
| MXPA03003511A (es) * | 2000-10-27 | 2004-05-04 | Leo Pharma As | Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide. |
| ATE397902T1 (de) * | 2001-11-30 | 2008-07-15 | Koninkl Philips Electronics Nv | Bildverarbeitungsverfahren und system zum hervorheben von strukturen in verrauschten bildern |
| GB0317868D0 (en) * | 2003-07-30 | 2003-09-03 | Disperse Ltd | Biliquid foams with a high alcohol content and products formulated therefrom |
| GB0404403D0 (en) * | 2004-02-27 | 2004-03-31 | Disperse Ltd | Dispersions |
| FR2871696B1 (fr) * | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
-
2007
- 2007-03-15 EP EP07251094A patent/EP1970049A1/de not_active Withdrawn
- 2007-09-27 US US11/905,163 patent/US20080227759A1/en not_active Abandoned
-
2008
- 2008-03-14 ES ES08718736T patent/ES2368535T3/es active Active
- 2008-03-14 DK DK08718736.5T patent/DK2139452T3/da active
- 2008-03-14 WO PCT/GB2008/000894 patent/WO2008110815A1/en not_active Ceased
- 2008-03-14 EP EP08718736A patent/EP2139452B1/de active Active
- 2008-03-14 TW TW097109114A patent/TWI434705B/zh active
- 2008-03-14 CN CN201510208126.2A patent/CN104815329A/zh active Pending
- 2008-03-14 AT AT08718736T patent/ATE516797T1/de not_active IP Right Cessation
- 2008-03-14 CN CN200880008496A patent/CN101674808A/zh active Pending
- 2008-03-14 AR ARP080101054A patent/AR065740A1/es unknown
- 2008-03-14 CA CA2680405A patent/CA2680405C/en active Active
- 2008-03-14 RU RU2009138045/15A patent/RU2466716C2/ru active
- 2008-03-14 AU AU2008224704A patent/AU2008224704B2/en active Active
- 2008-03-14 JP JP2009553212A patent/JP5414542B2/ja active Active
-
2009
- 2009-09-14 ZA ZA2009/06382A patent/ZA200906382B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104815329A (zh) | 2015-08-05 |
| CN101674808A (zh) | 2010-03-17 |
| JP5414542B2 (ja) | 2014-02-12 |
| EP1970049A1 (de) | 2008-09-17 |
| JP2010521445A (ja) | 2010-06-24 |
| TW200902084A (en) | 2009-01-16 |
| ES2368535T3 (es) | 2011-11-18 |
| RU2466716C2 (ru) | 2012-11-20 |
| WO2008110815A1 (en) | 2008-09-18 |
| CA2680405C (en) | 2016-08-16 |
| AU2008224704B2 (en) | 2013-09-12 |
| DK2139452T3 (da) | 2011-11-14 |
| CA2680405A1 (en) | 2008-09-18 |
| EP2139452A1 (de) | 2010-01-06 |
| TWI434705B (zh) | 2014-04-21 |
| EP2139452B1 (de) | 2011-07-20 |
| AU2008224704A1 (en) | 2008-09-18 |
| ZA200906382B (en) | 2010-11-24 |
| AR065740A1 (es) | 2009-06-24 |
| RU2009138045A (ru) | 2011-04-20 |
| US20080227759A1 (en) | 2008-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2139452T3 (da) | Topisk polyaphronsammensætning med D-vitamin og corticosteroid | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0815407A2 (pt) | Composições e métodos para controlar nematódeos | |
| BRPI0819573A2 (pt) | Composição e artigo | |
| EP2086561A4 (de) | Topische formulierung und ihre verwendungen | |
| DK2111126T3 (da) | Forbedret stabilitet i vitamin- og mineraltilskud | |
| DE602007013240D1 (de) | Zusammensetzung mit sarsasapogenin | |
| PL2152237T3 (pl) | Nowa kompozycja farmaceutyczna | |
| BRPI1013421A2 (pt) | composição parasticida tópica, e, uso de uma composição | |
| ATE526567T1 (de) | Zusammensteller und zusammenstellungsverfahren | |
| BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes | |
| ZA201002072B (en) | Topical composition | |
| BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0816789A2 (pt) | Goji e inflamação | |
| HRP20141261T1 (xx) | Spojevi tioninija i njihove uporabe | |
| BRPI0814165A2 (pt) | Composições tópicas endoparasiticidas | |
| IL210820A0 (en) | Topical anti-inflammatory compositions and uses thereof | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| ZA201003055B (en) | Topical composition | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
| DK2185151T3 (da) | Antiinflammatorisk sammensætning | |
| BRPI0812000A2 (pt) | Métodos e composições para administração de oxibutinina | |
| EP2110424A4 (de) | Klebharzzusammensetzung und klebeverfahren | |
| EP2124938A4 (de) | Topische formulierung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |